Skip to content

Search for Studies

Search Results

The iPeer2Peer (iP2P) program is an online peer support mentorship program that provides modelling and reinforcement by trained young adult peer mentors to adolescent mentees with the same condition. A quasi-experimental single-arm pre-post study design will be employed across three sites. We will recruit 40 mentees (12-17 years of age) and 12-15 mentors (18-30 years of age) who will undergo training in mentoring and the use of eHealth technology. Mentor-mentee pairings will connect over 15 weeks through video calls and text messaging to provide peer support and encourage disease self-management skills. Data will be collected using standardized instruments and interviews across three time points.

Conditions:
Heart Failure
Location:
  • The Hospital for Sick Children, Toronto, Ontario, Canada
Sex:
ALL
Ages:
12 - 30

This study is being done to answer the following question: Are there types of early-stage vulvar cancer that require either less or more treatment than the usual approach?

Conditions:
Vulvar Squamous Cell Carcinoma
Location:
  • BCCA - Vancouver, Vancouver, British Columbia, Canada
  • CHUM-Centre Hospitalier de l'Universite de Montreal, Montreal, Quebec, Canada
  • Juravinski Cancer Centre at Hamilton Health Sciences, Hamilton, Ontario, Canada
  • CIUSSS de l'Estrie - Centre hospitalier, Sherbrooke, Quebec, Canada
  • Odette Cancer Centre, Toronto, Ontario, Canada
  • Hotel-Dieu de Quebec, Québec, Quebec, Canada
Sex:
FEMALE
Ages:
Over 18

This study is being done to answer the following question: Does stereotactic body radiation therapy (SBRT) provide better cancer control compared to standard radiation therapy (RT) for those with advanced head and neck cancer?

Conditions:
Advanced Head and Neck Cancer
Location:
  • Cross Cancer Institute, Edmonton, Alberta, Canada
  • Odette Cancer Centre, Toronto, Ontario, Canada
Sex:
ALL
Ages:
Over 18

The purpose of this study is to compare the effects on participants' and liver cancer by adding a drug that is used on its own to treat this disease to a combination of two other drugs which is also used to treat liver cancer, compared to the two-drug combination alone.

Conditions:
Hepatocellular Carcinoma
Location:
  • Arthur J.E. Child Comprehensive Cancer Centre, Calgary, Alberta, Canada
  • London Health Sciences Centre Research Inc., London, Ontario, Canada
  • CHUM-Centre Hospitalier de l'Universite de Montreal, Montreal, Quebec, Canada
  • Kingston Health Sciences Centre, Kingston, Ontario, Canada
  • Ottawa Hospital Research Institute, Ottawa, Ontario, Canada
  • Waterloo Regional Health Network (WRHN), Kitchener, Ontario, Canada
  • University Health Network, Toronto, Ontario, Canada
  • BCCA - Vancouver, Vancouver, British Columbia, Canada
  • Trillium Health Partners - Credit Valley Hospital, Mississauga, Ontario, Canada
Sex:
ALL
Ages:
Over 18

Background: A lack of education, resources, and support for family carers of young adults with psychotic illnesses leaves them ill-equipped to support their loved one. Although family support groups exist, few groups offer evidence-based, skills-focused, psychoeducation taught by certified professionals and provided on a public-health level. By equipping families with skills and knowledge, public healthcare harnesses a powerful ally to maintain community stabilization. Aims: The primary study goal is to implement a psychoeducation intervention for family carers supporting young adults with psychosis to reduce family burden and foster community stabilization of service users. Methods: A longitudinal pre-post design will be used to assess the long-term effectiveness of the psychoeducation intervention for family carers supporting a young adult with psychosis on service utilization and functional indexes. Nine expert-reviewed, and family peer-informed psychoeducation modules are administered in 2-hour sessions over 9 weeks to family carers. Conclusion: Presenting the novel approach of an expert-reviewed, peer-informed psychoeducation intervention for family carers, with a focus on knowledge and skill development, the researchers contribute to literature and best practice in patient and family-centered care.

Conditions:
Psychotic Disorders | Family Members | Anosognosia | Paranoia
Location:
  • Royal Alexandra Hospital, Edmonton, Alberta, Canada
  • University of Alberta Hospital, Edmonton, Alberta, Canada
  • Grey Nuns Community Hospital, Edmonton, Alberta, Canada
  • Alberta Hospital Edmonton, Edmonton, Alberta, Canada
Sex:
ALL
Ages:
17 - 27

To evaluate the safety and effectiveness of the SpaceIT™ Hydrogel System in patients undergoing External Beam Radiotherapy (EBRT) for the treatment of prostate cancer.

Conditions:
Prostate Cancer
Location:
  • Princess Margaret Cancer Centre, Toronto, Ontario, Canada
  • The Ottawa Hospital - General Campus, Ottawa, Ontario, Canada
  • Sunnybrook Health Sciences Centre-Hospital, Toronto, Ontario, Canada
Sex:
MALE
Ages:
Over 18

This randomized clinical trial (RCT) aims to compare clinical and radiographic outcomes of different partial wrist fusion techniques in participants with post-traumatic wrist arthritis. Participants with stage II or III scapholunate advanced collapse (SLAC) or scaphoid nonunion advanced collapse (SNAC) who meet the eligibility criteria will be randomly assigned to one of two parallel groups: Group A (partial wrist arthrodesis without triquetral excision i.e. four-corner arthrodesis), or Group B (partial wrist arthrodesis with triquetral excision i.e. three-corner or capitolunate arthrodesis with triquetral excision). The results of this study will provide evidence to guide surgeons in determining the ideal wrist fusion technique in the management of patients with post-traumatic wrist arthritis requiring surgery.

Conditions:
Joint Diseases | Arthritis | Musculoskeletal Diseases | Post-traumatic; Arthrosis | Wrist Arthritis | Wrist...
Location:
  • Lawson Health Research Institute, London, Ontario, Canada
  • Western Hand & Upper Limb Facility, Sturgeon Community Hospital, St. Albert, Alberta, Canada
  • South Health Campus, Calgary, Alberta, Canada
  • University of Saskatchewan, Saskatoon, Saskatchewan, Canada
  • Peter Lougheed Centre, Calgary, Alberta, Canada
  • The Ottawa Hospital - Civic Campus, Ottawa, Ontario, Canada
Sex:
ALL
Ages:
18 - 75

The purpose of this extension study is to provide continued treatment with Roche investigational medicinal product (IMP\[s\]) monotherapy or Roche IMP(s) combined with other agent(s) or comparator agent(s) for eligible participants with cancer who are still on study treatment at the time of roll-over from the parent study and who do not have access to the study treatment locally.

Conditions:
Cancer
Location:
  • Princess Margaret Cancer Center, Toronto, Ontario, Canada
Sex:
ALL
Ages:
Over 18

This study is being done to answer the following question: Can the addition of a new drug to the usual treatment lower the chance of primary central nervous system lymphoma growing or spreading? This study is being done to find out if this approach is better or worse than the usual approach for this type of cancer. The usual approach is defined as the care most people get for Primary Central Nervous System Lymphoma (PCNSL).

Conditions:
Non-Hodgkin Lymphoma
Location:
  • University Health Network, Toronto, Ontario, Canada
  • The Research Institute of the McGill University, Montreal, Quebec, Canada
  • Ottawa Hospital Research Institute, Ottawa, Ontario, Canada
  • BCCA - Vancouver, Vancouver, British Columbia, Canada
  • CHU de Quebec-Hopital l'Enfant-Jesus (HEJ), Quebec City, Quebec, Canada
  • Arthur J.E. Child Comprehensive Cancer Centre, Calgary, Alberta, Canada
  • Juravinski Cancer Centre at Hamilton Health Sciences, Hamilton, Ontario, Canada
  • CHU de Quebec-Hopital l'Enfant-Jesus (HEJ), Québec, Quebec, Canada
Sex:
ALL
Ages:
Over 18

The usual approach for most patients who are not in a study is treatment with docetaxel. This study is being done to answer the following question: Can the chance of prostate cancer growing or spreading be lowered by adding a drug to the usual approach? This study is being done to find out if this approach is better or worse than the usual approach for prostate cancer. The usual approach is defined as the care most people get for prostate cancer.

Conditions:
Metastatic Prostate Cancer | Metastatic Castration-Resistant Prostate Cancer
Location:
  • Cross Cancer Institute, Edmonton, Alberta, Canada
  • London Health Sciences Centre Research Inc., London, Ontario, Canada
  • CHU de Quebec-Hopital l'Enfant-Jesus (HEJ), Québec, Quebec, Canada
  • William Osler Health System, Brampton, Ontario, Canada
  • University Health Network, Toronto, Ontario, Canada
  • Waterloo Regional Health Network (WRHN), Kitchener, Ontario, Canada
  • The Jewish General Hospital, Montreal, Quebec, Canada
  • BCCA - Vancouver, Vancouver, British Columbia, Canada
  • Odette Cancer Centre, Toronto, Ontario, Canada
Sex:
MALE
Ages:
Over 18